论文信息 - BCR‐ABL1 molecular remission after 90Y‐epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B‐ALL: proof of principle - 字舞流文

BCR‐ABL1 molecular remission after 90Y‐epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B‐ALL: proof of principle

P. Chevallier | C. Bodet-Milin | F. Kraeber-Bodéré | J. Delaunay | D. Goldenberg | N. Robillard | W. Wegener | T. Eugène | T. Guillaume | A. Menard | M. Escoffre‐Barbe | C. Houerou | M. Escoffre-barbe